(MENAFN- GetNews)


"Electrical Stimulation Devices Market"Electrical Stimulation Devices Market By Product Type (Wired Devices And Wireless Devices), By Indication (Neurological Disorders, Pain Management, Musculoskeletal Disorders, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, And Others), by geography, is projected to grow at a noteworthy CAGR forecast till 2030 owing to the rising prevalence of musculoskeletal disorders and technological innovation in product development

The global functional electrical stimulation (FES) devices market is expected to expand at a CAGR of 8.2% between 2024 and 2030. This growth is primarily fueled by the rising global prevalence of musculoskeletal disorders, an increasing focus on pain management therapies, and continuous technological progress in device innovation, all of which are anticipated to accelerate market growth in the coming years.

DelveInsight's Electrical Stimulation Devices Market Insights report offers an in-depth evaluation of current and projected market trends, market shares of key players, drivers, challenges, and barriers, as well as emerging trends shaping the competitive landscape of the Electrical Stimulation Devices market.

Request for a sample page report @

Key Takeaways from the Electrical Stimulation Devices Market Report

According to DelveInsight estimates, North America is projected to remain the leading region in the global Electrical Stimulation Devices market throughout the forecast period.

Several key players are actively contributing to market growth, including HASOMED GmbH, Restorative Therapies, Bioness Inc., Trulife, Otto Bock, Odstock Medical Limited, Hobbs Rehabilitation, MotoMed, Medline Industries, LP, and g.tec medical engineering GmbH, among others.

Noteworthy developments include:

• October 29, 2020: g.tec medical engineering GmbH received FDA approval for its g.Estim FES, a neuromuscular electrical stimulator designed for supervised medical use as an adjunctive therapy for various health conditions.

• March 4, 2020: Bioness Inc. secured FDA approval for the L100 Go System, developed to support ankle dorsiflexion in adults with foot drop or muscle weakness resulting from upper motor neuron disease or injury, such as stroke or spinal cord damage.

To read more about the latest highlights related to the Electrical Stimulation Devices market, get a snapshot of the key highlights entailed in the Global Electrical Stimulation Devices Market Report

Electrical Stimulation Devices Overview

Electrical stimulation devices are medical instruments that apply precisely controlled electrical impulses to nerves, muscles, or targeted brain areas to help restore function, alleviate pain, or facilitate healing. These devices are extensively utilized in rehabilitation, chronic pain management, and neurological therapy.

Electrical Stimulation Devices Market Insights

North America is projected to remain the leading market for functional electrical stimulation (FES) devices throughout the forecast period, primarily driven by the increasing incidence of stroke, cerebral palsy, and musculoskeletal disorders. The rising obesity rates in the region further heighten the risk of these conditions, thereby boosting the demand for FES-based therapies. Additionally, the strong presence of prominent market players continues to support the region's market dominance.

In the United States, data from the U.S. Bureau of Labor Statistics (2018) recorded 272,780 musculoskeletal disorder cases within the private sector, highlighting a significant patient base likely to benefit from FES treatment. Moreover, chronic pain remains a major contributing factor to market growth. According to the CDC (2020), in 2019, about 20.4% of U.S. adults suffered from chronic pain, while 7.4% experienced pain severe enough to frequently restrict daily activities, further fueling the demand for functional electrical stimulation devices across the country.

To know more about why North America is leading the market growth in the Electrical Stimulation Devices market, get a snapshot of the Electrical Stimulation Devices Market Outlook

Electrical Stimulation Devices Market Dynamics

The functional electrical stimulation (FES) devices market is experiencing steady growth, primarily fueled by the rising global prevalence of musculoskeletal disorders. FES devices play a crucial role in enhancing muscle mobility, improving strength, reducing spasticity, initiating muscle activity, and supporting movement memory formation. According to WHO (2021), an estimated 1.71 billion people worldwide were living with musculoskeletal conditions in 2020.

In the United Kingdom, data from Gov (2020) revealed that 18.5% of adults suffered from chronic back or joint pain, with a higher prevalence among women (20.9%) compared to men (15.9%). Similar trends observed globally highlight the increasing demand for FES devices. Market expansion is also supported by strategic collaborations among manufacturers aimed at improving rehabilitative care-for instance, Ekso Bionics®' partnership with HASOMED in December 2017 to integrate FES technology into the EksoGT Exoskeleton.

However, despite these positive drivers, high device costs and associated risks may pose challenges to the growth of the FES devices market during the forecast period.

Electrical Stimulation Devices Market Drivers:

• Rising prevalence of musculoskeletal disorders

• Technological innovation in product development

Get a sneak peek at the Electrical Stimulation Devices market dynamics

Scope of the Electrical Stimulation Devices Market Report:

• Coverage: Global

• Study Period: 2022 to 2032

• Key Electrical Stimulation Devices Companies: HASOMED GmbH, Restorative Therapies, Bioness Inc., Trulife, Otto Bock, Odstock Medical Limited, Hobbs Rehabilitation, MotoMed, Medline Industries, LP, g.tec medical engineering GmbH, and others.

Which MedTech key players in the Electrical Stimulation Devices market are set to emerge as the trendsetter, explore @ Electrical Stimulation Devices Companies

About DelveInsight

DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.

Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.

MENAFN03112025003238003268ID1110288814